Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome.

Zhang J, Bottiglieri T, McCullough PA.

Cardiorenal Med. 2017 Feb;7(2):104-117. doi: 10.1159/000452283. Epub 2016 Dec 29. Review.

PMID:
28611784
2.

Baicalein protects against oxLDL-caused oxidative stress and inflammation by modulation of AMPK-alpha.

Tsai KL, Hung CH, Chan SH, Shih JY, Cheng YH, Tsai YJ, Lin HC, Chu PM.

Oncotarget. 2016 Nov 8;7(45):72458-72468. doi: 10.18632/oncotarget.12788.

3.

Leptospirosis and Peripheral Artery Occlusive Disease: A Nationwide Cohort Analysis.

Chiu CH, Lin CL, Lee FY, Wang YC, Kao CH.

Medicine (Baltimore). 2016 Mar;95(11):e3127. doi: 10.1097/MD.0000000000003127.

4.

A Comparison of Measures of Endothelial Function in Patients with Peripheral Arterial Disease and Age and Gender Matched Controls.

Allan RB, Vun SV, Spark JI.

Int J Vasc Med. 2016;2016:2969740. doi: 10.1155/2016/2969740. Epub 2016 Jan 31.

5.

Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling.

Hung CH, Chan SH, Chu PM, Lin HC, Tsai KL.

Oncotarget. 2016 Mar 8;7(10):10773-87. doi: 10.18632/oncotarget.7387.

6.

Impaired Coronary Endothelial Vasorelaxation in a Preclinical Model of Peripheral Arterial Insufficiency.

Arce-Esquivel AA, Bunker AK, Simmons GH, Yang HT, Laughlin MH, Terjung RL.

J Heart Cardiol. 2015;1(2). doi: 10.15436/2378-6914/15/010. Epub 2015 Jun 29.

7.

Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease.

Chen J, Mohler ER, Xie D, Shlipak M, Townsend RR, Appel LJ, Ojo A, Schreiber M, Nessel L, Zhang X, Raj D, Strauss L, Lora CM, Rahman M, Hamm LL, He J; CRIC Study Investigators.

Nephrol Dial Transplant. 2016 Jul;31(7):1145-51. doi: 10.1093/ndt/gfv418. Epub 2015 Dec 18.

PMID:
26682964
8.

Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox.

DiStasi MR, Mund JA, Bohlen HG, Miller SJ, Ingram DA, Dalsing MC, Unthank JL.

Am J Physiol Heart Circ Physiol. 2015 Oct;309(7):H1207-17. doi: 10.1152/ajpheart.00180.2015. Epub 2015 Aug 21.

9.

Pathological periodontal pockets are associated with raised diastolic blood pressure in obese adolescents.

Zeigler CC, Wondimu B, Marcus C, Modéer T.

BMC Oral Health. 2015 Mar 24;15:41. doi: 10.1186/s12903-015-0026-6.

10.

Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs.

Joyner MJ, Casey DP.

Physiol Rev. 2015 Apr;95(2):549-601. doi: 10.1152/physrev.00035.2013. Review.

11.

Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?

Valdivielso P, Ramírez-Bollero J, Pérez-López C.

World J Diabetes. 2014 Oct 15;5(5):577-85. doi: 10.4239/wjd.v5.i5.577. Review.

12.

The relation between neutrophil-to-lymphocyte ratio and coronary chronic total occlusions.

Demir K, Avci A, Altunkeser BB, Yilmaz A, Keles F, Ersecgin A.

BMC Cardiovasc Disord. 2014 Sep 27;14:130. doi: 10.1186/1471-2261-14-130.

13.

Walking disability in patients with peripheral artery disease is associated with arterial endothelial function.

Grenon SM, Chong K, Alley H, Nosova E, Gasper W, Hiramoto J, Boscardin WJ, Owens CD.

J Vasc Surg. 2014 Apr;59(4):1025-34. doi: 10.1016/j.jvs.2013.10.084. Epub 2014 Jan 11.

14.

Clinical trials of adult stem cell therapy for peripheral artery disease.

Botham CM, Bennett WL, Cooke JP.

Methodist Debakey Cardiovasc J. 2013 Oct-Dec;9(4):201-5. Review. Erratum in: Methodist Debakey Cardiovasc J. 2014 Apr-Jun;10(2):134.

15.

MicroRNA-138 regulates hypoxia-induced endothelial cell dysfunction by targeting S100A1.

Sen A, Ren S, Lerchenmüller C, Sun J, Weiss N, Most P, Peppel K.

PLoS One. 2013 Nov 11;8(11):e78684. doi: 10.1371/journal.pone.0078684. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/53080a85-89cc-4a84-8fd9-0eb0c19cc05d. PLoS One. 2014;9(1). doi:10.1371/annotation/c7bddd8d-9f15-45f4-a886-740b351a39b6.

16.

Predictors of walking capacity in peripheral arterial disease patients.

Farah BQ, Souza Barbosa JP, Cucato GG, Chehuen Mda R, Gobbo LA, Wolosker N, Forjaz CL, Ritti-Dias RM.

Clinics (Sao Paulo). 2013 Apr;68(4):537-41. doi: 10.6061/clinics/2013(04)16.

17.

Exercise training and peripheral arterial disease.

Haas TL, Lloyd PG, Yang HT, Terjung RL.

Compr Physiol. 2012 Oct;2(4):2933-3017. doi: 10.1002/cphy.c110065. Review.

18.

Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art.

Radenković M, Stojanović M, Potpara T, Prostran M.

Biomed Res Int. 2013;2013:252158. doi: 10.1155/2013/252158. Epub 2013 Jan 8. Review.

19.

Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication.

Giugliano G, Perrino C, Schiano V, Brevetti L, Sannino A, Schiattarella GG, Gargiulo G, Serino F, Ferrone M, Scudiero F, Carbone A, Bruno A, Amato B, Trimarco B, Esposito G.

BMC Surg. 2012;12 Suppl 1:S19. doi: 10.1186/1471-2482-12-S1-S19. Epub 2012 Nov 15.

20.

Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway.

Ikeda Y, Aihara K, Yoshida S, Iwase T, Tajima S, Izawa-Ishizawa Y, Kihira Y, Ishizawa K, Tomita S, Tsuchiya K, Sata M, Akaike M, Kato S, Matsumoto T, Tamaki T.

J Biol Chem. 2012 Oct 5;287(41):34256-63. doi: 10.1074/jbc.M112.353532. Epub 2012 Aug 17.

Supplemental Content

Support Center